Table 5.
Disease-free survival: univariate analysis of prognostic clinicopathologic factors
| 3-yr survival (%) | 5-yr survival (%) | P-value | |
| Age (yr) | |||
| ≤ 62 | 46.7 | 21.7 | 0.76 |
| > 62 | 38.2 | 31.4 | |
| Gender | |||
| Male | 49.4 | 26.4 | 0.43 |
| Female | 25.1 | 20.7 | |
| Cirrhosis | |||
| Yes | 42.6 | 37.2 | 0.19 |
| No | 51.9 | 29.3 | |
| Serum AFP (ng/mL) | |||
| ≤ 200 | 36.5 | 20.1 | 0.66 |
| > 200 | 32.4 | 29.7 | |
| Tumor location | |||
| Spiegel lobe | 50.5 | 34.4 | 0.07 |
| Paracaval portion | 36.9 | 20.6 | |
| Caudate process | 41.0 | 26.2 | |
| Tumor size (cm) | |||
| ≤ 5 | 40.6 | 23.0 | 0.69 |
| > 5 | 44.0 | 26.4 | |
| Pringle maneuver | |||
| No | 40.4 | 22.6 | 0.66 |
| Yes | 36.1 | 19.8 | |
| Surgical margin | |||
| Positive | 42.6 | 22.8 | 0.08 |
| Negative | 55.2 | 30.7 | |
| Surgical treatment | |||
| Isolated caudate lobectomy | 43.4 | 24.0 | 0.35 |
| Extended hepatectomy | 41.7 | 35.8 | |
| Histologic grading | |||
| Differentiated | 42.1 | 24.2 | 0.42 |
| Undifferentiated | 33.9 | 28.7 | |
| Capsule | |||
| No | 36.3 | 19.0 | 0.65 |
| Yes | 43.8 | 26.3 | |
| Vascular invasion | |||
| No | 45.0 | 29.7 | 0.25 |
| Yes | 34.0 | 21.3 | |
| Daughter nodules | |||
| No | 56.1 | 36.8 | 0.09 |
| Yes | 45.3 | 25.0 |